{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T18:40:07Z","timestamp":1745174407924,"version":"3.40.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Start-up Fund for RAPs under the Strategic Hiring Scheme of Hong Kong Polytechnic University","award":["A0036603"],"award-info":[{"award-number":["A0036603"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Myasthenia gravis is a chronic neuromuscular disease that causes weakness. It\u2019s uncertain whether generic health instruments can adequately capture its impact. This study aimed to develop a scoring system to generate utility values for all health states defined by the myasthenia gravis quality of life 6-dimension (MGQoL-6D) classification in Chinese patients with myasthenia gravis (MG).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The data used in this study were obtained from a web-based cross-sectional study conducted in China. Patients with MG were invited to complete an online discrete choice experiment (DCE) survey. Each participant completed 10 randomly assigned choice pairs from a set of 40 choice pairs, with each pair comprising two health states and a duration attribute. Conditional logistic regression analysis was employed to analyse the data, which included responses from 300 patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Utility decrements estimated by conditional logit regression were generally monotonic, with the largest decrements observed for emotion (\u2212\u20090.419), social activity (\u2212\u20090.323), and hobbies and fun activities (\u2212\u20090.323). The MGQoL-6D utility scores ranged between \u2212\u20090.559 and 1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study established utility weights for the MGQoL-6D that can facilitate cost-utility analyses related to MG-related health interventions and technologies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12955-025-02370-2","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T18:24:07Z","timestamp":1745173447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimating a preference-based index for patients with myasthenia gravis from the MGQoL-6D measure"],"prefix":"10.1186","volume":"23","author":[{"given":"Richard Huan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"2370_CR1","doi-asserted-by":"publisher","unstructured":"Bubuioc AM, Kudebayeva A, Turuspekova S, et al. The epidemiology of myasthenia Gravis. J Med Life. 2021;14. https:\/\/doi.org\/10.25122\/jml-2020-0145.","DOI":"10.25122\/jml-2020-0145"},{"key":"2370_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-015-0298-1","volume":"13","author":"MI Boldingh","year":"2015","unstructured":"Boldingh MI, Dekker L, Maniaol AH, et al. An up-date on health-related quality of life in myasthenia Gravis -results from population based cohorts. Health Qual Life Outcomes. 2015;13:115. https:\/\/doi.org\/10.1186\/s12955-015-0298-1.","journal-title":"Health Qual Life Outcomes"},{"key":"2370_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, et al. Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia Gravis. Muscle Nerve. 2008;38:957\u201363.","journal-title":"Muscle Nerve"},{"key":"2370_CR4","doi-asserted-by":"publisher","unstructured":"Xu RH, Yu S, Liu J, et al. Developing the health state classification system for a condition-specific preference-based measure for patients with myasthenia Gravis. Disabil Rehabil. 2023;45. https:\/\/doi.org\/10.1080\/09638288.2022.2120096.","DOI":"10.1080\/09638288.2022.2120096"},{"key":"2370_CR5","doi-asserted-by":"publisher","unstructured":"Ludwig K, Ramos-Go\u00f1i JM, Oppe M, et al. To what extent do patient preferences differ from general population preferences? Value Health. 2021;24. https:\/\/doi.org\/10.1016\/j.jval.2021.02.012.","DOI":"10.1016\/j.jval.2021.02.012"},{"key":"2370_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jval.2024.10.3800","volume":"28","author":"D Rowen","year":"2025","unstructured":"Rowen D, McDool E, Carlton J, et al. Deriving a Preference-Weighted measure for people with hypoglycemia from the Hypo-RESOLVE QoL. Value Health. 2025;28:125\u201337. https:\/\/doi.org\/10.1016\/j.jval.2024.10.3800.","journal-title":"Value Health"},{"key":"2370_CR7","doi-asserted-by":"publisher","unstructured":"Mukuria C, Peasgood T, McDool E, et al. Valuing the EQ health and wellbeing short using time Trade-Off and a discrete choice experiment: A feasibility study. Value Health. 2023;26. https:\/\/doi.org\/10.1016\/j.jval.2023.02.008.","DOI":"10.1016\/j.jval.2023.02.008"},{"key":"2370_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jval.2021.03.007","volume":"24","author":"D Rowen","year":"2021","unstructured":"Rowen D, Powell P, Mukuria C, et al. Deriving a Preference-Based measure for people with Duchenne muscular dystrophy from the DMD-QoL. Value Health. 2021;24:1499\u2013510. https:\/\/doi.org\/10.1016\/j.jval.2021.03.007.","journal-title":"Value Health"},{"key":"2370_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.12.008","author":"T Thai","year":"2025","unstructured":"Thai T, Engel L, Ride J, et al. Developing an Australian value set for the recovering quality of Life-Utility index (ReQoL-UI) instrument using discrete choice experiment with duration. Value in health. Published Online First: January. 2025. https:\/\/doi.org\/10.1016\/j.jval.2024.12.008.","journal-title":"Published Online First: January"},{"key":"2370_CR10","doi-asserted-by":"publisher","first-page":"e0211343","DOI":"10.1371\/journal.pone.0211343","volume":"14","author":"N Uhlenbusch","year":"2019","unstructured":"Uhlenbusch N, L\u00f6we B, H\u00e4rter M, et al. Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study. PLoS ONE. 2019;14:e0211343\u20130211343.","journal-title":"PLoS ONE"},{"key":"2370_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13023-021-02008-8","volume":"16","author":"M Yao","year":"2021","unstructured":"Yao M, Xia Y, Feng Y, et al. Anxiety and depression in school-age patients with spinal muscular atrophy: a cross-sectional study. Orphanet J Rare Dis. 2021;16:385. https:\/\/doi.org\/10.1186\/s13023-021-02008-8.","journal-title":"Orphanet J Rare Dis"},{"key":"2370_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-023-01632-4","author":"RH Xu","year":"2023","unstructured":"Xu RH, Wong EL, Luo N, et al. The EORTC QLU-C10D: the Hong Kong valuation study. Eur J Health Econ Published Online First. 2023. https:\/\/doi.org\/10.1007\/s10198-023-01632-4.","journal-title":"Eur J Health Econ Published Online First"},{"key":"2370_CR13","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s11136-020-02536-z","volume":"29","author":"EM Gamper","year":"2020","unstructured":"Gamper EM, King MT, Norman R, et al. EORTC QLU-C10D value sets for Austria, Italy, and Poland. Qual Life Res. 2020;29:2485\u201395. https:\/\/doi.org\/10.1007\/s11136-020-02536-z.","journal-title":"Qual Life Res"},{"key":"2370_CR14","doi-asserted-by":"publisher","unstructured":"Chapple A, May C, Campion P. Parental guilt: the part played by the clinical geneticist. J Genet Couns. 1995;4. https:\/\/doi.org\/10.1007\/BF01408408.","DOI":"10.1007\/BF01408408"},{"key":"2370_CR15","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Z\u00fa\u00f1iga B, Pulido Moyano R, Pousada Fern\u00e1ndez M, et al. The experience of parents of children with rare diseases when communicating with healthcare professionals: towards an integrative theory of trust. Orphanet J Rare Dis. 2019;14. https:\/\/doi.org\/10.1186\/s13023-019-1134-1.","DOI":"10.1186\/s13023-019-1134-1"},{"key":"2370_CR16","doi-asserted-by":"publisher","unstructured":"Velvin G, Dammann B, Haagensen T, et al. Work participation in adults with rare genetic diseases - a scoping review. BMC Public Health. 2023;23. https:\/\/doi.org\/10.1186\/s12889-023-15654-3.","DOI":"10.1186\/s12889-023-15654-3"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02370-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-025-02370-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02370-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T18:24:08Z","timestamp":1745173448000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-025-02370-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2370"],"URL":"https:\/\/doi.org\/10.1186\/s12955-025-02370-2","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and informed consent were approved by the ethics committee of the Institutional Review Board of the Hong Kong Polytechnic University (Ref No.: HSEARS20240226001), and written informed consent was collected from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}